	Skeletal Muscle Index, Tumor and Systemic Immunity, and Survival in Advanced Pancreatic Ductal Adenocarcinoma. Cancer Med Ma Y, Jia R, Fan M, Deng G, Liu T, Wang Y, Li Y, Zhang N, Pang F, Shi Y, Zhang Y, Pan Y, Wang Q, Wang Z, Dai G. PMID: 42885341 [PubMed - indexed for MEDLINE]
	Preoperative Zinc Deficiency as a Novel Prognostic Predictor for Postoperative Recurrence in Hepatocellular Carcinoma. Nutrients Adachi Y, Shimada S, Mizukami S, Takizawa T, Enomoto K, Makino K, Takahata H, Takahashi H, Imai K, Yokoo H. PMID: 42884598 [PubMed - indexed for MEDLINE]
	Prognostic Value and Longitudinal Dynamics of Multigene Circulating Tumor DNA in Advanced Pancreatic Cancer Treated with 5-Fluorouracil-Based Chemotherapy. Int J Mol Sci Lee GY, Chun JW, Lee DE, Jang JH, Lee WJ, Kim HP, Lee ST, Woo SM, Kong SY. PMID: 42883913 [PubMed - indexed for MEDLINE]
	Prognostic and Clinicopathological Significance of CD74 Expression in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Int J Mol Sci Vacariu IA, Ilie SM, Vere CC, Turcu-Stiolica A, Manthopoulou E, Pahomeanu MR, Tcaciuc E, Toma SC, Ungureanu BS. PMID: 42883736 [PubMed - indexed for MEDLINE]
	Second Primary Malignancies in Gastrointestinal Cancer Survivors: Epidemiology, Risk Factors, and Future Prediction Models. Cancers (Basel) Yadav J, Balizzakiwa T, Goyal H. PMID: 42882890 [PubMed]
	Negotiating Mortality: A Qualitative Systematic Review and Thematic Synthesis of the Psychosocial Experiences of Pancreatic Cancer Across the Illness Trajectory. Cancers (Basel) Cook L, Prue G, McShane C, Krishnasamy M, Furness K, McLaughlin S, Mitchell G. PMID: 42882871 [PubMed]
	Pancreatic Cancer-Associated Pain Management Beyond Opioids: Integrating Oncological Treatment, Palliative Care, and Interventional Pain Medicine. Cancers (Basel) Zelenai F, Bakos E, Süller-Torma V, Dank M, Madurka I, Horváth O. PMID: 42882821 [PubMed]
	Expression of Annexin A4 in Cancer: A Tissue Microarray Study Involving More than 17,600 Cancers from 148 Tumor Entities. Cancers (Basel) Völkel C, Malas N, Gehrisch F, Menz A, Lutz F, Chirico V, Viehweger F, Dum D, Schlichter R, Hinsch A, Fraune C, Bernreuther C, Büyücek S, Kluth M, Hube-Magg C, Makrypidi-Fraune G, Schraps N, Möller K, Luebke AM, Lebok P, Sauter G, Lennartz M, Clauditz TS, Marx AH, Simon R, Burandt E, Gorbokon N, Tsourlakis MC, Minner S, Krech T, Freytag M, Reiswich V, Steurer S. PMID: 42882772 [PubMed]
	Aldehyde Dehydrogenase 2 Activity Assessed Using the Acetaldehyde Breath Test Is Associated with Benign Pancreatic Disease and Pancreatic Cancer: A Case-Control Study. J Clin Med Kamikihara Y, Tanoue S, Oda K, Sasaki F, Yamazato Y, Shibata R, Kojima I, Morinaga Y, Hinokuchi M, Arima S, Idichi T, Mataki Y, Ohtsuka T, Fujita H, Koriyama C, Hashimoto S. PMID: 42882005 [PubMed]
	Intrapancreatic Fat Deposition and Prostate Cancer Risk: A Primary Case-Control Study. Technol Cancer Res Treat Wang H, Li H, Zhang K, Wu L, Wang C, Fang D, Yu Y, Yang X, Sun S, Chen X, Bi S, Wen H. PMID: 42880771 [PubMed - indexed for MEDLINE]
	Interpretable CT-based radiomics nomogram integrating clinical and semantic features for preoperative grading of pancreatic neuroendocrine neoplasms: a shap-based analysis. Cancer Treat Res Commun Liu JB, Tang C, Yang MR, Li YX, Kong R, Guo Q, Lyu ZN, Liu Y, Peng P. PMID: 42880114 [PubMed - as supplied by publisher]
	Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy. Front Immunol Hou Y, Tan Z. PMID: 42877588 [PubMed - indexed for MEDLINE]
	Strategy for early diagnosis of pancreatic cancer. Front Gastroenterol (Lausanne) Sharma RK, Singh A, Sharma G, Dawra S, Rana SS. PMID: 42877528 [PubMed]
	Research trends and knowledge structure of pancreatic cancer and type 2 diabetes mellitus research: a two-decade CiteSpace analysis. Front Endocrinol (Lausanne) Dong Z, Zhou T, Ma S, Chen X, Lai Y. PMID: 42876703 [PubMed - indexed for MEDLINE]
	Cancer risks associated with BRCA1 and BRCA2: Overview and management. Cancer Breen KE, Vashisth S, Liu YL. PMID: 42875977 [PubMed - indexed for MEDLINE]
	When to Operate After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer: A Critical Review and Multidimensional Decision Framework. J Gastrointest Surg Ho W, Xu W, Zhang J, Guo J. PMID: 42874796 [PubMed - as supplied by publisher]
	Strategies to develop therapeutic cancer vaccines for pancreatic cancer. Lancet Gastroenterol Hepatol Coppi MM, Graciotti M, Digklia A, Kandalaft LE. PMID: 42874623 [PubMed - as supplied by publisher]
	Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: A Prospective Phase II Study With a Propensity Score-Matched Analysis. J Surg Res Ishido K, Kimura N, Nagase H, Wakasa Y, Wakiya T, Tsuruta S, Miura T, Hakamada K. PMID: 42874369 [PubMed - as supplied by publisher]
	Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers. Curr Oncol Rep Lima DDSP, Silva MDS, Soares MDR, Lima Terceiro LE, de Lima NTR, de Oliveira GD, de Souza TA, Rodrigues-Junior VS, Cibulski SP. PMID: 42873463 [PubMed - indexed for MEDLINE]
	From Nature to Medicine: Overcoming the Limitations of Herbal Therapeutics for Pancreatic Cancer Treatment Based on Nanotechnology. Nanomaterials (Basel) Muteeb G, Basem Y, Kotb AA, Magdy NT, Alghuwainem GY, Aatif M, Farhan M, Khafaga DSR. PMID: 42873039 [PubMed]

Articles 1 - 20 / 61873

Page 1 of 3094



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy